Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluad-H5N1 in healthy adults and elderly
NCT00841763Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2008
- Primary completion
- Apr 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of Audenz in Influenza A H5N1 infection (H5N1), sponsored by Novartis. Started Oct 2008; status: completed.
02
Drugs
Audenz
03
Conditions
Influenza A H5N1 infection (H5N1)
Beyond the preview
Go deeper on NCT00841763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00841763.